From marginal gains to clinical utility: machine learning-based percutaneous coronary intervention risk prediction
Muhammad Ibtsaam Qadir1, Ravi S Hira2,3, Fiona R Kolbinger1,4,5
1Weldon School of Biomedical Engineering, Purdue University, 206 S. Martin Jischke Drive, West Lafayette, IN 47907, USA.
European Heart Journal. Digital Health
|March 20, 2025
Abstract
No abstract available in PubMed .
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.2K
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.4K
